Carbapenem-Resistant Enterobacteriaceae
"Carbapenem-Resistant Enterobacteriaceae" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Strains of Enterobacteriaceae that are resistant to CARBAPENEMS, primarily due to the acquisition of carbapenemase (BETA-LACTAMASE) genes.
Descriptor ID |
D000073182
|
MeSH Number(s) |
B03.440.450.425.189 B03.660.250.150.097
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Carbapenem-Resistant Enterobacteriaceae".
Below are MeSH descriptors whose meaning is more specific than "Carbapenem-Resistant Enterobacteriaceae".
This graph shows the total number of publications written about "Carbapenem-Resistant Enterobacteriaceae" by people in this website by year, and whether "Carbapenem-Resistant Enterobacteriaceae" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2017 | 1 | 0 | 1 |
2018 | 4 | 0 | 4 |
2023 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Carbapenem-Resistant Enterobacteriaceae" by people in Profiles.
-
Luterbach CL, Chen L, Komarow L, Ostrowsky B, Kaye KS, Hanson B, Arias CA, Desai S, Gallagher JC, Novick E, Pagkalinawan S, Lautenbach E, Wortmann G, Kalayjian RC, Eilertson B, Farrell JJ, McCarty T, Hill C, Fowler VG, Kreiswirth BN, Bonomo RA, van Duin D. Transmission of Carbapenem-Resistant Klebsiella pneumoniae in US Hospitals. Clin Infect Dis. 2023 Jan 13; 76(2):229-237.
-
Kazmierczak KM, Tsuji M, Wise MG, Hackel M, Yamano Y, Echols R, Sahm DF. In vitro activity of cefiderocol, a siderophore cephalosporin, against a recent collection of clinically relevant carbapenem-non-susceptible Gram-negative bacilli, including serine carbapenemase- and metallo-?-lactamase-producing isolates (SIDERO-WT-2014 Study). Int J Antimicrob Agents. 2019 Feb; 53(2):177-184.
-
Kohler PP, Melano RG, Patel SN, Shafinaz S, Faheem A, Coleman BL, Green K, Armstrong I, Almohri H, Borgia S, Borgundvaag E, Johnstone J, Katz K, Lam F, Muller MP, Powis J, Poutanen SM, Richardson D, Rebbapragada A, Sarabia A, Simor A, McGeer A. Emergence of Carbapenemase-Producing Enterobacteriaceae, South-Central Ontario, Canada1. Emerg Infect Dis. 2018 09; 24(9):1674-1682.
-
Garg M, Talmud J, Repanshek Z. Commentary. Ann Emerg Med. 2018 07; 72(1):60-61.
-
Karlowsky JA, Lob SH, Kazmierczak KM, Young K, Motyl MR, Sahm DF. In Vitro Activity of Imipenem-Relebactam against Clinical Isolates of Gram-Negative Bacilli Isolated in Hospital Laboratories in the United States as Part of the SMART 2016 Program. Antimicrob Agents Chemother. 2018 07; 62(7).
-
Karlowsky JA, Lob SH, Kazmierczak KM, Badal RE, Young K, Motyl MR, Sahm DF. In Vitro Activity of Imipenem against Carbapenemase-Positive Enterobacteriaceae Isolates Collected by the SMART Global Surveillance Program from 2008 to 2014. J Clin Microbiol. 2017 06; 55(6):1638-1649.